Cargando…
WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index
Objective: In this study, we identify clinical, radiographic, and histopathologic prognosticators of overall, early, and post-median recurrence in World Health Organization (WHO) grade I meningiomas. We also determine a clinically relevant cutoff for MIB-1 to identify patients at high risk for recur...
Autores principales: | Haddad, Alexander F., Young, Jacob S., Kanungo, Ishan, Sudhir, Sweta, Chen, Jia-Shu, Raleigh, David R., Magill, Stephen T., McDermott, Michael W., Aghi, Manish K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483477/ https://www.ncbi.nlm.nih.gov/pubmed/32983999 http://dx.doi.org/10.3389/fonc.2020.01522 |
Ejemplares similares
-
DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery
por: Winther, Theo L., et al.
Publicado: (2017) -
CDK 4/6 inhibitors for the treatment of meningioma
por: Young, Jacob S., et al.
Publicado: (2022) -
FORGE: A Novel Scoring System to Predict the MIB-1 Labeling Index in Intracranial Meningiomas
por: Wach, Johannes, et al.
Publicado: (2021) -
Unsuccessful external validation of the MAC-score for predicting increased MIB-1 index in patients with spinal meningiomas
por: El-Hajj, Victor Gabriel, et al.
Publicado: (2022) -
MAC-spinal meningioma score: A proposal for a quick-to-use scoring sheet of the MIB-1 index in sporadic spinal meningiomas
por: Wach, Johannes, et al.
Publicado: (2022)